Literature DB >> 8214279

Morphologic effects of artemisinin in Plasmodium falciparum.

Y Maeno1, T Toyoshima, H Fujioka, Y Ito, S R Meshnick, A Benakis, W K Milhous, M Aikawa.   

Abstract

Ultrastructural changes induced in Plasmodium falciparum by artemisinin were studied in vitro. Electron microscopic autoradiography was performed on infected erythrocytes that were exposed in vitro to 3H-dihydroartemisinin and 14C-artemisinin. These drugs consistently were located in food vacuoles and mitochondria. Two hours after administration, changes were observed in parasite mitochondria, rough endoplasmic reticulum, and nuclear envelope. At four hours, in addition to the earlier changes, nuclear membranes and, to a lesser extent, some plasma membranes formed myelin figures. In addition, there was a disappearance of ribosomes, and a destruction of food vacuole membranes. These changes may lead to the total disorganization of the parasites. Approximately 30% of the parasites manifested these alterations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8214279     DOI: 10.4269/ajtmh.1993.49.485

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  27 in total

1.  Pharmacodynamic interaction of doxycycline and artemisinin in Plasmodium falciparum.

Authors:  Ulrike Sponer; Somsak Prajakwong; Gerhard Wiedermann; Herwig Kollaritsch; Gunther Wernsdorfer; Walther H Wernsdorfer
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  The role of heme and the mitochondrion in the chemical and molecular mechanisms of mammalian cell death induced by the artemisinin antimalarials.

Authors:  Amy E Mercer; Ian M Copple; James L Maggs; Paul M O'Neill; B Kevin Park
Journal:  J Biol Chem       Date:  2010-11-08       Impact factor: 5.157

3.  Eosin B as a novel antimalarial agent for drug-resistant Plasmodium falciparum.

Authors:  Kristen M Massimine; Michael T McIntosh; Lanxuan T Doan; Chloé E Atreya; Stephan Gromer; Worachart Sirawaraporn; David A Elliott; Keith A Joiner; R Heiner Schirmer; Karen S Anderson
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

4.  Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum.

Authors:  Quinton L Fivelman; Ipemida S Adagu; David C Warhurst
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

5.  Ultrastructural and real-time microscopic changes in P. falciparum-infected red blood cells following treatment with antimalarial drugs.

Authors:  Navakanit Sachanonta; Kesinee Chotivanich; Urai Chaisri; Gareth D H Turner; David J P Ferguson; Nicholas P J Day; Emsri Pongponratn
Journal:  Ultrastruct Pathol       Date:  2011-10       Impact factor: 1.094

6.  Cryo transmission X-ray imaging of the malaria parasite, P. falciparum.

Authors:  Eric Hanssen; Christian Knoechel; Nectarios Klonis; Nurhidanatasha Abu-Bakar; Samantha Deed; Mark LeGros; Carolyn Larabell; Leann Tilley
Journal:  J Struct Biol       Date:  2010-09-06       Impact factor: 2.867

7.  Artemisinin directly targets malarial mitochondria through its specific mitochondrial activation.

Authors:  Juan Wang; Liying Huang; Jian Li; Qiangwang Fan; Yicheng Long; Ying Li; Bing Zhou
Journal:  PLoS One       Date:  2010-03-08       Impact factor: 3.240

Review 8.  Artemisinin Action and Resistance in Plasmodium falciparum.

Authors:  Leann Tilley; Judith Straimer; Nina F Gnädig; Stuart A Ralph; David A Fidock
Journal:  Trends Parasitol       Date:  2016-06-09

Review 9.  Progress in the research of artemisinin-related antimalarials: an update.

Authors:  H J Woerdenbag; N Pras; W van Uden; T E Wallaart; A C Beekman; C B Lugt
Journal:  Pharm World Sci       Date:  1994-08-05

10.  Effects of antimalarial drugs on movement of Plasmodium falciparum.

Authors:  Jaiaue Wongtanachai; Kamolrat Silamut; Nicholas P J Day; Arjen Dondorp; Urai Chaisri
Journal:  Southeast Asian J Trop Med Public Health       Date:  2012-01       Impact factor: 0.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.